Xcout Intel
83Bar, Inc.
83Bar, Inc. is a patient activation and clinical trial recruitment company headquartered in Austin, Texas. The firm provides proprietary digital platforms that connect individuals with clinical research through engagement and recording tools.
Subscribe to see 83Bar, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
83Bar, Inc. at a glance
83Bar, Inc. is a healthcare technology systems company headquartered in United States. Its most recent funding round, Debt, raised $7.5M in October 2025. Xcout tracks 21 named people at 83Bar, Inc., including Seth Nelson (Chief Executive Officer).
83Bar, Inc. leadership
- Seth NelsonChief Executive Officer
- K Terence O'HaraChief Financial Officer
- Terry O HaraChief Financial Officer
- Mike CernikChief Technology Officer
- Sue HrimChief Clinical Officer
- Bob BaurysFounder
15 more named people on record for 83Bar, Inc., with roles, board committees and tenure — see the full roster →
83Bar, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Debt | $7.5M | 1 named | |
| SEC Form D filing | $4.6M | — | |
| SEC Form D filing | $2.5M | — | |
| — | Undisclosed | 2 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
83Bar, Inc. competitors
A few of 83Bar, Inc.'s closest competitors — see the full list of competitors and alternatives →
SubjectWell is a U.S.-based patient access company established in 2012 and headquartered in Austin, Texas. It delivers intelligence, predictability, and operational efficiency to clinical trials by connecting domestic and international business clients with patients.
Science 37 operates as a clinical research site and patient access company that facilitates direct-to-patient and decentralized clinical trials. It provides trial sponsors with enrollment, retention, and research-grade nursing solutions to help patients participate in medical studies from their homes. The company serves clinical trial sponsors, researchers, and patients seeking remote access to medical studies.
Power Life Sciences, Inc., operating as Power, was founded in 2021 and is headquartered in San Francisco, California. The company builds digital platforms designed to streamline clinical trial recruitment and participation for patients. It operates within the healthcare technology sector to connect individuals with medical research opportunities.
Trialbee is a healthtech company that provides technology and services for recruiting and enrolling patients into clinical trials. It serves pharmaceutical and biotechnology companies, contract research organizations, and clinical research teams seeking to improve patient identification, engagement, and enrollment.
Ancora.ai is a Swiss digital-health company that uses artificial intelligence to help patients find clinical trials relevant to their conditions and circumstances. Its platform also supports healthcare professionals and clinical-trial sponsors in improving trial discovery and patient recruitment.
Paradigm Health provides an AI-native clinical trial platform and services that connect trial sponsors and healthcare providers. The company's technology helps optimize protocols, improve site selection, identify patients, accelerate enrollment, and collect trial data to streamline clinical research.
Get 83Bar, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about 83Bar, Inc.? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on 83Bar, Inc. in Xcout Intel
- 21 named people with titles, LinkedIn and board committees
- 4 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access